Kiran Nistala - Feb 27, 2025 Form 4 Insider Report for Zura Bio Ltd (ZURA)

Role
Chief Medical Officer and Head of Development
Signature
/s/ Kiran Nistala
Stock symbol
ZURA
Transactions as of
Feb 27, 2025
Transactions value $
$0
Form type
4
Date filed
3/3/2025, 05:02 PM
Previous filing
Jun 21, 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZURA Employee Share Option (Right to Buy) Award $0 +342K $0.00 342K Feb 27, 2025 Class A Ordinary Shares 342K $1.20 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One fourth (1/4th) of the shares subject to the option award shall vest on February 27, 2026, and one twelfth (1/12th) of the remaining shares subject to the option award shall vest in equal quarterly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.

Remarks:

Chief Medical Officer and Head of Development